Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells.

Dagher OK, Jaffa MA, Habib A, Ziyadeh FN, Jaffa AA.

PLoS One. 2019 May 14;14(5):e0216908. doi: 10.1371/journal.pone.0216908. eCollection 2019.

2.

Proteome profiling in the aorta and kidney of type 1 diabetic rats.

Al Hariri M, Elmedawar M, Zhu R, Jaffa MA, Zhao J, Mirzaei P, Ahmed A, Kobeissy F, Ziyadeh FN, Mechref Y, Jaffa AA.

PLoS One. 2017 Nov 9;12(11):e0187752. doi: 10.1371/journal.pone.0187752. eCollection 2017.

3.

Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes.

Abou Msallem J, Chalhoub H, Al-Hariri M, Saad L, Jaffa MA, Ziyadeh FN, Jaffa AA.

Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F980-90. doi: 10.1152/ajprenal.00233.2015. Epub 2015 Oct 7. Retraction in: Am J Physiol Renal Physiol. 2016 Nov 1;311(5):F1085.

4.

Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy.

Eid S, Abou-Kheir W, Sabra R, Daoud G, Jaffa A, Ziyadeh FN, Roman L, Eid AA.

J Biol Regul Homeost Agents. 2013 Jul-Sep;27(3):693-703.

PMID:
24152838
5.

20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.

Eid S, Maalouf R, Jaffa AA, Nassif J, Hamdy A, Rashid A, Ziyadeh FN, Eid AA.

PLoS One. 2013 Aug 2;8(8):e70029. doi: 10.1371/journal.pone.0070029. Print 2013.

6.

Effects of weight reduction regimens and bariatric surgery on chronic kidney disease in obese patients.

Abou-Mrad RM, Abu-Alfa AK, Ziyadeh FN.

Am J Physiol Renal Physiol. 2013 Sep 1;305(5):F613-7. doi: 10.1152/ajprenal.00173.2013. Epub 2013 Jul 3. Review.

7.

End stage renal disease in six patients with beta-thalassemia intermedia.

Mallat NS, Musallam KM, Mallat SG, Ziyadeh FN, Koussa S, Taher AT.

Blood Cells Mol Dis. 2013 Oct;51(3):146-8. doi: 10.1016/j.bcmd.2013.05.001. Epub 2013 May 31. No abstract available.

PMID:
23732019
8.

Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney.

Nasrallah MP, Ziyadeh FN.

Semin Nephrol. 2013 Jan;33(1):54-65. doi: 10.1016/j.semnephrol.2012.12.005. Review.

PMID:
23374894
9.

Glomerular hyperfiltration and proteinuria in transfusion-independent patients with β-thalassemia intermedia.

Ziyadeh FN, Musallam KM, Mallat NS, Mallat S, Jaber F, Mohamed AA, Koussa S, Taher AT.

Nephron Clin Pract. 2012;121(3-4):c136-43. doi: 10.1159/000339787. Epub 2012 Dec 8.

PMID:
23235469
10.

Global renal gene expression profiling analysis in B2-kinin receptor null mice: impact of diabetes.

Jaffa MA, Kobeissy F, Al Hariri M, Chalhoub H, Eid A, Ziyadeh FN, Jaffa AA.

PLoS One. 2012;7(9):e44714. doi: 10.1371/journal.pone.0044714. Epub 2012 Sep 18.

11.

Emerging therapies for diabetic nephropathy patients: beyond blockade of the Renin-Angiotensin system.

Tanios BY, Ziyadeh FN.

Nephron Extra. 2012 Oct 30;2(1):278-82. doi: 10.1159/000343312. Print 2012 Jan.

12.

Angiogenic factors.

Khoury CC, Ziyadeh FN.

Contrib Nephrol. 2011;170:83-92. doi: 10.1159/000324950. Epub 2011 Jun 9. Review.

PMID:
21659761
13.

The cardiorenal syndrome in diabetes mellitus.

Karnib HH, Ziyadeh FN.

Diabetes Res Clin Pract. 2010 Sep;89(3):201-8. doi: 10.1016/j.diabres.2010.05.022. Review.

PMID:
20599286
14.

A 5-year survey of biopsy proven kidney diseases in Lebanon: significant variation in prevalence of primary glomerular diseases by age, population structure and consanguinity.

Karnib HH, Gharavi AG, Aftimos G, Mahfoud Z, Saad R, Gemayel E, Masri B, Assaad S, Badr KF, Ziyadeh FN.

Nephrol Dial Transplant. 2010 Dec;25(12):3962-9. doi: 10.1093/ndt/gfq302. Epub 2010 Jun 4.

15.

Vascular endothelial growth factor and diabetic nephropathy.

Chen S, Ziyadeh FN.

Curr Diab Rep. 2008 Dec;8(6):470-6. Review.

PMID:
18990304
16.

Steroid treatment of drug-induced acute interstitial nephritis.

Karnib HH, Ziyadeh FN.

Kidney Int. 2008 Nov;74(10):1360; author reply 1360-1. doi: 10.1038/ki.2008.470. No abstract available.

17.

Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy.

Ziyadeh FN.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S38-41. doi: 10.1016/j.diabres.2008.09.016. Epub 2008 Oct 7. Review.

PMID:
18842317
18.

Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.

Ziyadeh FN, Wolf G.

Curr Diabetes Rev. 2008 Feb;4(1):39-45. Review.

PMID:
18220694
19.

The utility of the transtubular potassium gradient in the evaluation of hyperkalemia.

Choi MJ, Ziyadeh FN.

J Am Soc Nephrol. 2008 Mar;19(3):424-6. doi: 10.1681/ASN.2007091017. Epub 2008 Jan 23.

20.

Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria.

Wang A, Ziyadeh FN, Lee EY, Pyagay PE, Sung SH, Sheardown SA, Laping NJ, Chen S.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1657-65. Epub 2007 Sep 5.

21.

Taurine intestinal absorption and renal excretion test in diabetic patients: a pilot study.

Merheb M, Daher RT, Nasrallah M, Sabra R, Ziyadeh FN, Barada K.

Diabetes Care. 2007 Oct;30(10):2652-4. Epub 2007 Jul 31. No abstract available.

PMID:
17666467
22.

Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.

Wolf G, Ziyadeh FN.

Nephron Physiol. 2007;106(2):p26-31. Epub 2007 Jun 6. Review.

PMID:
17570945
23.

Blockade of vascular endothelial growth factor signaling ameliorates diabetic albuminuria in mice.

Sung SH, Ziyadeh FN, Wang A, Pyagay PE, Kanwar YS, Chen S.

J Am Soc Nephrol. 2006 Nov;17(11):3093-104. Epub 2006 Sep 20.

24.

Leptin and renal fibrosis.

Wolf G, Ziyadeh FN.

Contrib Nephrol. 2006;151:175-83. Review.

PMID:
16929141
25.

Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications.

Cohen MP, Ziyadeh FN, Chen S.

J Lab Clin Med. 2006 May;147(5):211-9. Review. No abstract available.

26.

Assessment of 115 candidate genes for diabetic nephropathy by transmission/disequilibrium test.

Ewens KG, George RA, Sharma K, Ziyadeh FN, Spielman RS.

Diabetes. 2005 Nov;54(11):3305-18.

27.

Evidence linking glycated albumin to altered glomerular nephrin and VEGF expression, proteinuria, and diabetic nephropathy.

Cohen MP, Chen S, Ziyadeh FN, Shea E, Hud EA, Lautenslager GT, Shearman CW.

Kidney Int. 2005 Oct;68(4):1554-61.

29.

Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.

Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN.

Nephrol Dial Transplant. 2005 Jul;20(7):1320-8. Epub 2005 Apr 19.

PMID:
15840669
31.

Albumin up-regulates the type II transforming growth factor-beta receptor in cultured proximal tubular cells.

Wolf G, Schroeder R, Ziyadeh FN, Stahl RA.

Kidney Int. 2004 Nov;66(5):1849-58.

32.

Cultured tubule cells from TGF-beta1 null mice exhibit impaired hypertrophy and fibronectin expression in high glucose.

Chen S, Hoffman BB, Lee JS, Kasama Y, Jim B, Kopp JB, Ziyadeh FN.

Kidney Int. 2004 Apr;65(4):1191-204.

33.

Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator.

Ziyadeh FN.

J Am Soc Nephrol. 2004 Jan;15 Suppl 1:S55-7. Review.

34.
35.

Why should an angiogenic factor modulate tubular structure in diabetic nephropathy? Some answers, more questions.

Ziyadeh FN, Wolf G.

Kidney Int. 2003 Aug;64(2):758-9. Review. No abstract available.

36.

Retinoids as a potential treatment for experimental puromycin-induced nephrosis.

Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ.

Br J Pharmacol. 2003 Jun;139(4):823-31.

37.

Overview: combating diabetic nephropathy.

Ziyadeh FN, Sharma K.

J Am Soc Nephrol. 2003 May;14(5):1355-7. Review. No abstract available.

38.

Reversibility of established diabetic glomerulopathy by anti-TGF-beta antibodies in db/db mice.

Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN.

Biochem Biophys Res Commun. 2003 Jan 3;300(1):16-22.

PMID:
12480514
39.
40.

Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells.

Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN.

Biochem Biophys Res Commun. 2002 Sep 6;296(5):1356-65.

PMID:
12207925
41.

Involvement of the transforming growth factor-β system in the pathogenesis of diabetic nephropathy.

Ziyadeh FN, Isono M, Chen S.

Clin Exp Nephrol. 2002 Sep;6(3):125-9. doi: 10.1007/s101570200021.

PMID:
24989950
42.

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.

Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.

Kidney Int. 2002 Sep;62(3):901-13.

43.

Inhibiting albumin glycation in vivo ameliorates glomerular overexpression of TGF-beta1.

Cohen MP, Ziyadeh FN, Hong SW, Shearman CW, Hud E, Lautenslager GT, Iglesias-de la Cruz MC, Chen S.

Kidney Int. 2002 Jun;61(6):2025-32.

44.

Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation.

Strutz F, Zeisberg M, Ziyadeh FN, Yang CQ, Kalluri R, Müller GA, Neilson EG.

Kidney Int. 2002 May;61(5):1714-28.

45.

Leptin and renal disease.

Wolf G, Chen S, Han DC, Ziyadeh FN.

Am J Kidney Dis. 2002 Jan;39(1):1-11. Review.

PMID:
11774095
46.

The renin-angiotensin system in diabetic nephropathy.

Chen S, Wolf G, Ziyadeh FN.

Contrib Nephrol. 2001;(135):212-21. Review. No abstract available.

PMID:
11705286
47.

The key role of the transforming growth factor-beta system in the pathogenesis of diabetic nephropathy.

Chen S, Hong SW, Iglesias-de la Cruz MC, Isono M, Casaretto A, Ziyadeh FN.

Ren Fail. 2001 May-Jul;23(3-4):471-81. Review.

PMID:
11499562
48.

TGF-beta: a crucial component of the pathogenesis of diabetic nephropathy.

Goldfarb S, Ziyadeh FN.

Trans Am Clin Climatol Assoc. 2001;112:27-32; discussion 33. Review.

49.
50.

Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression.

Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN.

Kidney Int. 2001 Apr;59(4):1315-23.

Supplemental Content

Loading ...
Support Center